Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Monopar Therapeutics Inc (MNPR)

Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Monopar Therapeutics Inc 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 USA

www.monopartx.com Employees: 16 P: 847-388-0349

Sector:

Medical

Description:

Monopar Therapeutics Inc. is a biopharmaceutical company. It is focused on developing drugs for cancer patients. The company's intellectual property pipeline consists of Validive(R), Camsirubicin (MNPR-201) and MNPR-101 which are in clinical stage. Monopar Therapeutics Inc. is based in Wilmette, United States.

Key Statistics

Overview:

Market Capitalization, $K 396,880
Enterprise Value, $K 351,060
Shares Outstanding, K 6,683
Float, K 5,313
% Float 79.50%
Short Interest, K 1,279
Short Float 19.15%
Days to Cover 4.07
Short Volume Ratio 0.41
% of Insider Shareholders 20.50%
% of Institutional Shareholders 1.83%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -15,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,440 K
EBIT, $ -21,610 K
EBITDA, $ -21,610 K

Growth:

1-Year Return 15.70%
3-Year Return 236.49%
5-Year Return 39.74%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -82.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.48 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -3.44
EPS Growth vs. Prev Qtr -37.14%
EPS Growth vs. Prev Year -29.73%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 08/13/24

MNPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.72%
Return-on-Assets % -24.81%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.54
Book Value/Share 22.94
Interest Coverage -3.93
60-Month Beta 1.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar